Gilead Research Scholars Gilead Research Scholars
  • Available Programs |
  • Login / Register
Gilead Research Scholars
  • Program Information
    • Program Overview
    • Scientific Focus
    • Eligibility
    • Selection Process and Scoring Criteria
    • Scientific Review Committee
  • Application Information
    • Application Overview
    • Proposal & Budget Guidelines
    • Program Timeline
    • Inquiries/Contact Information
    • Downloads
  • Award Recipients
  • Apply
  • Contact
  • FAQ

Below are Gilead’s Research Scholar Program Solid Tumor Awardees and their research titles. As the program values diverse voices and innovative research topics to address areas of unmet medical need, you do not need to duplicate previous research topics in order to be successful for an Award. 

Any basic, translational or clinical research research proposal that addresses an area of unmet medical need in Solid Tumors is welcome.

2023 Award Recipients

Award Recipient Image

Elie Rassy, MD, MSc, MPH

Gustave Roussy

"A cOmprehensive study to understand the canceR Immunity cyclE iN occulT brEast canceR"

Award Recipient Image

Gillian Vandekerkove, PhD

University of British Columbia

"Circulating tumor DNA for the prediction of prognosis and treatment resistance in metastatic urothelial carcinoma​"

Award Recipient Image

Céline Blaye, MD, PhD

Institut Bergonié

"Impact of tumor-promoting immunosuppressive myeloid cells on the acquisition of a stemness phenotype by breast cancer cells"
Award Recipient Image

Carmine DeAngelis, MD, PhD

University of Napes Federico II

"Elucidating the role of the interferon signaling pathway as a mediator of resistance to CDK4/6 inhibitors in ER-positive breast cancer

2022 Award Recipients

Award Recipient Image

Matteo Lambertini, MD, PhD

IRCCS Ospedale Policlinico San Martino - University of Genova

"Addressing reproductive issues in young women with breast cancer in the current era of personalized medicine and effective targeted therapies"

Award Recipient Image

Xiaozheng Liu, PhD

VIB-KU Leuven

"Metabolic Evolution of Breast Cancer Metastasis Predicts Metastasis Risk at Early Stage"

Award Recipient Image

Sebastian Vosberg, PhD

Medical University of Graz

"In silico characterization of the tumor immune microenvironment in luminal breast cancer"

​

September 2022, IHQ-UNB-2550

GILEAD and the GILEAD logo are registered trademarks of Gilead Sciences, Inc., or one of its related companies.

© 2020 Gilead Sciences, Inc. All rights reserved. 

Privacy Policy 

Terms of Use 

Funding Considerations